Inolitazone (hydrochloride hydrate)
Inolitazone hydrochloride hydrate (Efatutazone hydrochloride hydrate) is a novel PPARγ high-affinity agonist, with an EC50 value one-fiftieth that of Rosiglitazone , and shows no inhibitory effect on RIE cells that do not express PPARγ. Inolitazone hydrochloride hydrate can be used in the research of cancer[1][2].
Product Specifications
CAS Number
1048002-36-3
Product Name Alternative
Efatutazone (hydrochloride hydrate) ; CS-7017 (hydrochloride hydrate) ; RS5444 (hydrochloride hydrate)
UNSPSC
12352005
Target
PPAR
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC1=C(N)C(C)=CC(OC2=CC(N(C)C(COC3=CC=C(CC4C(NC(S4)=O)=O)C=C3)=N5)=C5C=C2)=C1.O.Cl.Cl
Molecular Formula
C27H30Cl2N4O5S
Molecular Weight
593.52
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PPARγ
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-Phosphomevalonate kinase PMVK Antibody Picoband®, Carrier-free
